Protai
PrivateLast Round
Seed
Mar 15, 2023
Total Funding Raised
$20M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Protai is a biotechnology company that has developed an end-to-end AI-based platform that comprehensively maps the course of disease on the protein level, enhancing the ability to observe cellular function and improve the way new drugs are discovered.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Protai Comparables
Compare Protai with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Foreseen Biotechnology | 86% | |
| ProFound Therapeutics | 86% | |
| Promise Bio | 84% |
Protai Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 15, 2023 | ||||
| Seed | Jan 5, 2022 |
Key People
Founding team and executive leadership
Protai Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Maj Invest Equity A/S | Seed |
| Grove Ventures | Seed |
| Pitango Venture Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 162% MoM, reaching 2.7K.
- Oct 23, 2025
Attending ACR Convergence 2025 to expand into Immunology & Inflammation.
Protai Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Protai's valuation, stock price, and market status.
Is Protai a public or private company?
Protai is a private company.
What is the current stock price of Protai?
Protai is a private company with no public stock price. No recent secondary market data is available.
How much is Protai worth (valuation)?
Valuation information for Protai is not publicly available.
Can I buy Protai stock?
Protai shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Protai's last funding round?
Protai's most recent funding round was Seed on March 15, 2023.
Who are the main investors in Protai?
Key investors in Protai include Grove Ventures, Pitango Venture Capital.
Will Protai IPO soon?
No public IPO plans have been announced for Protai.
How can I track Protai secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Protai's secondary market activity and sign up for updates.